Glenmark’s Ryaltris Close To Entry In Major Eastern Europe Market

Indian Firm Has Launched Already In Ukraine, Australia And South Africa

 
• By Dean Rudge
  
Russia_Night
Ryaltris is under review with the US FDA, as well as regulators across Europe, Canada and Brazil. • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin